Mortality in nursing home patients with congestive heart failure

Journal of the American Medical Directors Association

Volumn 4, Issue 4, 2003, Pages 220-221

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL;

AGED; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; DIGOXIN BLOOD LEVEL; DOSE RESPONSE; DRUG TOLERABILITY; EDITORIAL; ELDERLY CARE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; HYPOTENSION; MORTALITY; NURSING HOME; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; SENSORY DYSFUNCTION; SYSTOLIC BLOOD PRESSURE;

EID: 0042530279     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70350-3     Document Type: Editorial

References (29)

1. Hutt, E, Frederickson, E, Ecord M, Kramer A. Associations among Processes and Outcomes of Care for Medicare Nursing Home Residents with Acute Heart Failure. J Am Med Dir Assoc 2003;4:195-199.
2. Aronow WS, Ahn C, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 1991;67:295-299.
3. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999;84:611-612.
4. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol 2000;85: 1382-1384.
5. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993;71:602-604.
6. Arling ML. Outcomes of ACE inhibitor use in nursing facility residents with congestive heart failure. Ann Long-Term Care 1998;6:237-241.
7. Ahmed A, Kiefe CI, Allman R, et al. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc 2002;50:1659-1666.
8. Philbin EF, Rocco TA Jr., Lindenmuth NW, et al. Systolic versus diastolic heart failure in community practice: Clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-613.
9. Sueta CA, Russo A, Schenck A, et al. Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients ≥65 years hospitalized with a left ventricular ejection fraction ≥50%. Am J Cardiol 2003;91:363-365.
10. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999;100:2312-2318.
11. Aronow WS, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 1998;113:867-869.
12. Aronow WS. Echocardiography should be performed in all elderly patients with congestive heart failure. J Am Geriatr Soc 1994;42:1300-1302.
13. Konstam MA, Dracup K, Baker DW, et al. Heart failure: management of patients with left-ventricular systolic dysfunction. Quick Reference Guide for Clinicians, No. 11, AHCPR Publication No. 94-0613. Rockville, MD: Agency for Health Care Policy and Research, June, 1994: 1-21.
14. Williams JF Jr., Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995;26:1376-1398.
15. American Medical Directors Association. Heart failure. Clinical Practice Guideline. Columbia, MD: American Medical Directors Association 1996;1-8.
16. Aronow WS. Commentary on American Geriatrics Society Clinical Practice Guidelines from AHCPR Guidelines on Heart Failure: Evaluation and Treatment of Patients with Left Ventricular Systolic Dysfunction. J Am Geriatr Soc 1998;46:525-529.
17. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
18. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
19. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
20. Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in chronic heart failure. N Engl J Med 2001;344:651-658.
21. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors. Am J Cardiol 1997;80:207-209.
22. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the International Society for Heart and Lung Transplantation. Endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2001;38:2101-2113.
23. Aronow WS, Ahn C, Kronzon I. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 2001;88:1298-1300.
24. Aronow WS. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment? Drugs Aging 1991;1:98-103.
25. Rich MW, McSherry F, Williford WO, et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG Study. J Am Coll Cardiol 2001;38:806-813.
26. Aronow WS. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons. J Lab Clin Med 2001;137: 316-323.
27. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Eng J Med 2002;347: 1403-1411.
28. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289:871-878.
29. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients. Heart Dis 2003, in press.